Conclusion
Since in the clinical setting stunning may coexist with persistently ischemic and infarcting myocardium, the ben fit el therapeutic interventions on the stunned myocardium must be weighed against potential deleterious effects on the ischemic myocardium.
Similar content being viewed by others
References
Ambrosio G, Jacobus WE, Bergmann CA, Weisman HF, Becker LC (1987) Preserved high energy phosphate metabolic reserve in globally stunned hearts despite reduction of basal ATP content and contractility. J Mol Cell Cardiol 19: 953–964
Ambrosio G, Weisfeldt M, Jacobus W, Flaherty J (1987) Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 75: 282–291
Bolli R (1995) Common methodological problems and artifacts associated with studies of myocardial stunning. Basic Res Cardiol 90: 257–262
Bolli R (1991) Superexide dismutase 10 years later: a drug in search of a use. J Am Coll Cardiol 18: 231–233
Bolli R, Zhu W-X, Myers ML, Hartley CJ, Roberts R (1985) Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent deterioration. Am J Cardiol 56: 964–968
Du Toit EF, Opie LH (1992) Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 70: 960–967
Ehring T, Baumgart D, Krajcar M, Hümmelgen M, Kompa S, Heusch G (1994) Attenuation of myocardial stunning by the ACE-inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins, but not nitric oxide. Circulation 90: 1368–1385
Ehring T, Böhm M, Heusch G (1992) The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol 20: 63–74
Ferrari R, Curello S, Ceconi C, Cargnoni A, Pasini E, Visioli O (1993) Cardioprotection by nisoldipine: role of timing of administration. Eur Heart J 14: 1258–1272
Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, George BS, Kereiakes DJ, Deitchman D, Gustafson N, Brinker JA, Becker LC, Mancini GBJ, Topol E, Werns SW (1994) Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89: 1982–1991
Görge G, Papageorgiou I, Lerch R (1990) Epinephrine-stimulated contractile and metabolic reserve in postischemic rat myocardium. Basic Res Cardiol 85: 595–605
Heusch G (1996) How should stunning be treated? Dial Cardiovasc Med 1: 35–39
Heusch G (1992) Myocardial stunning: a role for calcium antagonists during ischaemia? Cardiovasc Res 26: 14–19
Jeroudi MO, Triana FJ, Patel BS, Bolli R (1990) Effects of superoxide dismutase and catalase, given separately, on myocardial stunning. Am J Physiol 259: H889-H901
Przyklenk K, Kloner RA (1987) Acute effects of hydralazine and enalapril on contractile function of postischemic “stunned” myocardium. Am J Cardiol 60: 934–936
Przyklenk K, Kloner RA (1991) Calcium antagonists and stunned myocardium: importance for clinician? Cardiovasc Drugs Ther 5: 947–952
Qui Y, Galinases M, Ferrari R, Cargnoni A, Ezrin A, Hearse DJ (1992) PEG-SOD improves postischemic functional recovery and antioxidant status in blood-perfused rabbit hearts. Am J Physiol 263: H1243-H1249
Qui Y, Hearse DJ (1992) Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. J Thorac Cardiovasc Surg 103: 960–968
Schäfer S, Linder C, Heusch G (1990) Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery. Naunyn Schmiedebergs Arch Pharmacol 342: 206–213
Schulz R, Guth BD, Pieper K, Martin C, Heusch G (1992) Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res 70: 1282–1295
Schulz R, Rose J, Martin C, Brodde OE, Heusch G (1993) Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation 88: 684–695
Sheiban I, Tonni S, Benussi P, Martini A, Trevi GP (1993) Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning. Eur Heart J 14 (Suppl A): 14–21
Sheiban I, Tonni S, Chizzoni A, Marini A, Trevi G (1997) Recovery of left ventricular function following early reperfusion in acute myocardial infarction: a potential role of the calcium antagonist nisoldipine. Cardiovasc Drugs Ther 11: 5–16
Triana JF, Li X-Y, Jamaluddin U, Thornby JI, Bolli R (1991) Postischemic myocardial “stunning”: Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res 69: 731–747
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heusch, G. Therapy of myocardial stunning. Basic Res Cardiol 92 (Suppl 2), 30–31 (1997). https://doi.org/10.1007/BF00797202
Issue Date:
DOI: https://doi.org/10.1007/BF00797202